ClearBridge Investments - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$219,573,912
+3.2%
4,840,695
-6.7%
0.21%
+9.9%
Q2 2023$212,830,961
+10.4%
5,187,204
-3.8%
0.19%
+4.3%
Q1 2023$192,695,117
-6.0%
5,391,581
-0.6%
0.18%
-8.9%
Q4 2022$204,926,506
-19.8%
5,425,642
-6.0%
0.20%
-21.7%
Q3 2022$255,379,000
+14.9%
5,773,892
-3.9%
0.26%
+24.6%
Q2 2022$222,335,000
-7.3%
6,005,818
-7.3%
0.21%
+15.0%
Q1 2022$239,872,000
+34.0%
6,476,033
+10.1%
0.18%
+47.5%
Q4 2021$179,019,000
-27.2%
5,882,982
-19.7%
0.12%
-30.3%
Q3 2021$245,758,000
-9.6%
7,327,322
+7.5%
0.18%
-7.4%
Q2 2021$271,874,000
-18.3%
6,815,601
-7.9%
0.19%
-23.8%
Q1 2021$332,837,000
-14.9%
7,402,967
+7.1%
0.25%
-17.9%
Q4 2020$390,982,000
+13.3%
6,915,147
-4.9%
0.30%
+1.7%
Q3 2020$345,121,000
-23.6%
7,273,365
-5.1%
0.30%
-27.2%
Q2 2020$451,765,000
+18.9%
7,662,224
-4.6%
0.41%
-1.0%
Q1 2020$379,860,000
-21.5%
8,034,264
+1.1%
0.41%
+2.7%
Q4 2019$483,928,000
-13.1%
7,947,576
-14.5%
0.40%
-17.5%
Q3 2019$556,619,000
-8.9%
9,290,924
-2.2%
0.49%
-8.1%
Q2 2019$610,696,000
-20.8%
9,502,032
+0.0%
0.53%
-22.3%
Q1 2019$770,978,000
+37.4%
9,498,310
-8.5%
0.68%
+19.9%
Q4 2018$561,160,000
+6.3%
10,380,319
+1.4%
0.57%
+25.1%
Q3 2018$528,021,000
+17.1%
10,236,939
-5.4%
0.45%
+23.0%
Q2 2018$450,874,000
-6.3%
10,820,120
-0.9%
0.37%
-18.7%
Q1 2018$481,358,000
-12.9%
10,920,109
-0.6%
0.45%
-11.2%
Q4 2017$552,536,000
-4.7%
10,984,818
-4.0%
0.51%
-8.4%
Q3 2017$580,000,000
-3.6%
11,439,851
-3.3%
0.56%
-5.6%
Q2 2017$601,684,000
+26.1%
11,827,881
-0.4%
0.59%
+23.1%
Q1 2017$477,302,000
-17.2%
11,873,179
-1.5%
0.48%
-24.3%
Q4 2016$576,475,000
+45.3%
12,052,583
+11.3%
0.63%
+41.8%
Q3 2016$396,752,000
+51.2%
10,828,375
-3.9%
0.45%
+44.2%
Q2 2016$262,411,000
-41.8%
11,267,127
+1.3%
0.31%
-42.4%
Q1 2016$450,544,000
-23.2%
11,124,548
+17.4%
0.54%
-20.8%
Q4 2015$586,768,0009,474,7040.68%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 6,913,172$330,657,00012.25%
TANAKA CAPITAL MANAGEMENT INC 84,953$4,063,0009.51%
Sicart Associates LLC 280,315$13,407,0009.26%
DOWLING & YAHNKE LLC 675,843$32,326,0003.62%
Opus Point Partners Management, LLC 77,550$3,709,0002.96%
Motley Fool Asset Management LLC 259,000$12,388,0002.75%
Motley Fool Wealth Management, LLC 333,604$15,956,0001.70%
ALTRINSIC GLOBAL ADVISORS LLC 921,174$44,060,0001.63%
PINNACLE ASSOCIATES LTD 1,572,045$75,191,0001.52%
Sonora Investment Management, LLC 121,703$5,821,054,0001.20%
View complete list of IONIS PHARMACEUTICALS INC shareholders